Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The alpha chain of the nascent polypeptide-associated complex (alpha-NAC) coactivator was shown to potentiate the activity of the homodimeric
c-Jun
activator, while transcription mediated by the c-Fos/
c-Jun
heterodimer was unaffected. The use of deletion mutants in pull-down assays revealed that alpha-NAC interacted with amino acids 1 to 89 of the
c-Jun
protein and that the coactivator could interact with both the unphosphorylated and the serine 73-phosphorylated form of
c-Jun
. N-terminal-deleted
c-Jun
protein failed to interact with alpha-NAC in mammalian two-hybrid assays, while mutant
c-Jun
proteins lacking the leucine zipper or the basic domain retained interaction with alpha-NAC in vivo. Kinetics studies with purified
c-Jun
homodimer and recombinant alpha-NAC proteins allowed determination of the mechanism of coactivation by alpha-NAC: the coactivator stabilized the AP-1 complex formed by the
c-Jun
homodimer on its DNA recognition sequence through an eightfold reduction in the dissociation constant (kd) of the complex. This effect of alpha-NAC was specific, because alpha-NAC could not stabilize the interactions of JunB or Sp1 with their cognate binding sites. Interestingly, the expression of alpha-NAC was first detected at 14.5 to 15 days postconception, concomitantly with the onset of ossification during embryogenesis. The
alpha-NAC protein
was specifically expressed in differentiated osteoblasts at the centers of ossification. Thus, the alpha-NAC gene product exhibits the properties of a developmentally regulated, bone-specific transcriptional coactivator.
...
PMID:Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription. 948 46
Nascent polypeptide-associated complex (NAC) protein, a heterodimeric complex of alpha- and beta-subunits, prevents mistargeting of nascent polypeptide chains to the endoplasmic reticulum membranes.
alpha-NAC
has sequence similarities with transcription-regulating proteins and has been reported to function as a transcriptional coactivator potentiating
c-Jun
-mediated transcription. Performing gene hunting using differential display-polymerase chain reaction, a downregulated sequence in the frontal cortex of patients with Alzheimer's disease (AD) and Down syndrome (DS) with AD-like neuropathology was identified as a-NAC with 100% homology. The significant decrease in
alpha-NAC
mRNA was shown by semiquantitative reverse transcription-polymerase chain reaction, and in parallel, the significant decrease of
alpha-NAC protein
, which was even more pronounced when related to either actin or neuron-specific enolase levels, was also observed in both disorders. Linear regression analysis revealed a strong, significant correlation between
alpha-NAC protein
and mRNA expression. In fetal DS brain, however, mRNA levels of
alpha-NAC
were comparable between DS and controls, suggesting that the decrease in
alpha-NAC
might be involved in the pathology of neurodegenerative diseases. The decrease in
alpha-NAC
as a transcriptional coactivator could contribute to the characteristic decline of the
c-Jun
-mediated transcriptional machinery and could function as the complementary mechanism in
c-Jun
-mediated apoptosis. Decreased
alpha-NAC
may result in the mistargeting, mistranslation, and proteolysis of proteins by affecting overall NAC function.
...
PMID:Human brain nascent polypeptide-associated complex alpha subunit is decreased in patients with Alzheimer' s disease and Down syndrome. 1210 94
Overexpression of the integrin-linked kinase (ILK) was shown to increase
c-Jun
-dependent transcription. We now show that this effect of ILK involves the
c-Jun
transcriptional coactivator, nascent polypeptide-associated complex and coactivator alpha (
alpha-NAC
). ILK phosphorylated
alpha-NAC
on residue Ser-43 upon adhesion of cells to fibronectin. Co-expression of constitutively active ILK with
alpha-NAC
led to the nuclear accumulation of the coactivator. Conversely,
alpha-NAC
remained in the cytoplasm of cells transfected with a dominant-negative ILK mutant, and a mutated
alpha-NAC
at phosphoacceptor position Ser-43 (S43A) also localized outside of the nucleus. The S43A
alpha-NAC
mutant could not potentiate the effect of ILK on
c-Jun
-dependent transcription. We conclude that ILK-dependent phosphorylation of
alpha-NAC
induced the nuclear accumulation of the coactivator and that phosphorylation of
alpha-NAC
by ILK is required for the potentiation of
c-Jun
-mediated responses by the kinase. The results represent one of the rare examples of a transcriptional coactivator shuttling between the cytosol and the nucleus.
...
PMID:Integrin-linked kinase regulates the nuclear entry of the c-Jun coactivator alpha-NAC and its coactivation potency. 1529 25